Brief: Zealand Pharma Q1 Operating Result DKK -539 Million
May 07 (Reuters) - Zealand Pharma Q1 revenue DKK 34 million. Q1 operating expenses DKK -573 million
Recent news on Zealand Pharma A/S
See all newsZealand falls as Berenberg cuts to 'hold' on fading survodutide hopes
Europe Research Roundup: Aixtron, Lenzing, Novo Nordisk
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up